Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Sept. 09, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Orthofix Medical Inc. ("Orthofix Medical" or the "Company") (NASDAQ: OFIX) investors of a class action representing investors that bought securities between October 11, 2022 and September 12, 2023, inclusive (the "Class Period"). Orthofix Medical investors have until October 21, 2024 to file a lead plaintiff motion. Investors are encouraged to ...

NEW YORK, Sept. 9, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Orthofix Medical Inc. (NASDAQ: OFIX). Shareholders who purchased shares of OFIX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/orthofix-loss-submission-form/?id=100731&from=4 CLASS PERIOD: October 11, 2022 t ...

NEW YORK, Sept. 5, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Orthofix Medical Inc. (NASDAQ: OFIX). Shareholders who purchased shares of OFIX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/orthofix-loss-submission-form/?id=100102&from=4 CLASS PERIOD: October 11, 2022 t ...

NEW YORK, Sept. 04, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Orthofix Medical Inc. (NASDAQ: OFIX) between October 11, 2022 and September 12, 2023, both dates inclusive (the "Class Period"), of the important October 21, 2024 lead plaintiff deadline. SO WHAT: If you purchased Orthofix common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee ...

PHILADELPHIA, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Berger Montague PC announces that a class action lawsuit was filed in the U.S. District Court for the Eastern District of Texas on behalf of those who acquired Orthofix Medical, Inc. ("Orthofix" or the "Company") (NASDAQ: OFIX) securities. If you suffered losses as a result of your investment in Orthofix (NASDAQ: OFIX) and would like to learn about a potential recovery, CLICK HERE. The lawsuit has been filed against Orthofix on behalf of purchasers of Orthofi ...

SAN DIEGO, Sept. 02, 2024 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired Orthofix Medical Inc. (NASDAQ: OFIX) stock between October 11, 2022 and September 12, 2023. Orthofix is a global spine and orthopedics company that offers biologics, spinal hardware, bone growth therapies, and specialized orthopedic solutions, among other things, to healthcare professionals throughout the world. For mor ...

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Orthofix To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $75,000 in Orthofix between October 11, 2022, and September 12, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, Aug. 31, 2024 /P ...

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Orthofix Medical Inc. due to significant losses suffered by investors following the termination of key executives and the subsequent decline in stock price [1][3][4]. Group 1: Company Overview - Orthofix Medical Inc. is publicly traded on NASDAQ under the ticker OFIX [1]. - The company recently faced a major leadership change, with the termination of its CEO, CFO, and Chief Legal Officer for cause due to violations of the company's code of conduct [4]. Group 2: Legal Actions and Investor Impact - Investors who incurred losses exceeding $75,000 between October 11, 2022, and September 12, 2023, are encouraged to discuss their legal rights and options with Faruqi & Faruqi [1]. - Following the announcement of executive terminations, Orthofix's stock price dropped by $5.62, or 30.2%, closing at $13.01 per share, indicating a significant impact on investor value [4]. - A federal securities class action has been filed against Orthofix, with a deadline of October 21, 2024, for investors to seek the role of lead plaintiff [1][5]. Group 3: Investigation and Whistleblower Encouragement - The investigation by Faruqi & Faruqi seeks information regarding Orthofix's conduct, inviting whistleblowers, former employees, and shareholders to come forward [6].

Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Aug. 29, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Orthofix Medical Inc. ("Orthofix Medical" or the "Company") (NASDAQ: OFIX) investors of a class action representing investors that bought securities between October 11, 2022 and September 12, 2023, inclusive (the "Class Period"). Orthofix Medical investors have until October 21, 2024 to file a lead plaintiff motion. Investors are encouraged to ...

LOS ANGELES , Aug. 29, 2024 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Orthofix Medical Inc. ("Orthofix" or the "Company") (NASDAQ: OFIX). Class Period: October 11, 2022 – September 12, 2023 Lead Plaintiff Deadline: October 21, 2024 If you are a shareholder who suffered a loss, click here to participate. The complaint filed alleges that, throughout the Class Period, Defendants fa ...